http://www.bmj.com/content/313/7058/643.2.extract
A firm of solicitors has won legal aid to research a possible claim against Hoffmann-La Roche, makers of the antimalarial drug mefloquine (Lariam), by more than 500 people who claim to have suffered side effects, including panic attacks, depression, and fits.
Lawrence Tucketts of Bristol has won the contract to investigate the strength of the case, a process which usually takes at least a year. The Legal Aid Board will then decide whether the chances of success and the likely compensation warrant the cost of full funding.
Most potential litigants have come forward …
No comments:
Post a Comment
Note: only a member of this blog may post a comment.